COHEN & STEERS INC (CNS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNS - US19247A1007 - Common Stock
65.91 USD
-2.87 (-4.17%)
65.91 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to CNS. CNS was compared to 237 industry peers in the Capital Markets industry. While CNS has a great profitability rating, there are some minor concerns on its financial health. CNS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- CNS had positive earnings in the past year.
- CNS had a negative operating cash flow in the past year.
- CNS had positive earnings in 4 of the past 5 years.
- CNS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of CNS (20.48%) is better than 97.48% of its industry peers.
- The Return On Equity of CNS (29.83%) is better than 95.38% of its industry peers.
- CNS has a Return On Invested Capital of 24.24%. This is amongst the best in the industry. CNS outperforms 97.90% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CNS is significantly above the industry average of 7.27%.
- The 3 year average ROIC (28.30%) for CNS is well above the current ROIC(24.24%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.48% | ||
| ROE | 29.83% | ||
| ROIC | 24.24% |
ROA(3y)20.51%
ROA(5y)25.29%
ROE(3y)38.03%
ROE(5y)48.18%
ROIC(3y)28.3%
ROIC(5y)38.19%
1.3 Margins
- CNS's Profit Margin of 29.73% is fine compared to the rest of the industry. CNS outperforms 73.53% of its industry peers.
- CNS's Profit Margin has declined in the last couple of years.
- CNS's Operating Margin of 33.83% is fine compared to the rest of the industry. CNS outperforms 65.13% of its industry peers.
- In the last couple of years the Operating Margin of CNS has declined.
- CNS's Gross Margin of 88.60% is amongst the best of the industry. CNS outperforms 92.86% of its industry peers.
- In the last couple of years the Gross Margin of CNS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.83% | ||
| PM (TTM) | 29.73% | ||
| GM | 88.6% |
OM growth 3Y-9.18%
OM growth 5Y-3.03%
PM growth 3Y-6.88%
PM growth 5Y-2.25%
GM growth 3Y0.74%
GM growth 5Y0.55%
2. Health
2.1 Basic Checks
- CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 9.23 indicates that CNS is not in any danger for bankruptcy at the moment.
- CNS's Altman-Z score of 9.23 is amongst the best of the industry. CNS outperforms 94.12% of its industry peers.
- There is no outstanding debt for CNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.23 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CNS has a Current Ratio of 0.79. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
- CNS's Current ratio of 0.79 is on the low side compared to the rest of the industry. CNS is outperformed by 63.45% of its industry peers.
- CNS has a Quick Ratio of 0.79. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.79, CNS is not doing good in the industry: 63.03% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
- CNS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.80%.
- CNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.74% yearly.
EPS 1Y (TTM)5.8%
EPS 3Y-5.81%
EPS 5Y3.74%
EPS Q2Q%3.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.55%
3.2 Future
- Based on estimates for the next years, CNS will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.66% on average per year.
- Based on estimates for the next years, CNS will show a small growth in Revenue. The Revenue will grow by 6.70% on average per year.
EPS Next Y8.49%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
EPS Next 5Y8.66%
Revenue Next Year8.33%
Revenue Next 2Y7.78%
Revenue Next 3Y7.24%
Revenue Next 5Y6.7%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 21.26, the valuation of CNS can be described as rather expensive.
- Based on the Price/Earnings ratio, CNS is valued a bit more expensive than 60.92% of the companies in the same industry.
- When comparing the Price/Earnings ratio of CNS to the average of the S&P500 Index (27.21), we can say CNS is valued slightly cheaper.
- The Price/Forward Earnings ratio is 19.60, which indicates a rather expensive current valuation of CNS.
- CNS's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of CNS to the average of the S&P500 Index (25.98), we can say CNS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.26 | ||
| Fwd PE | 19.6 |
4.2 Price Multiples
- 78.57% of the companies in the same industry are more expensive than CNS, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- CNS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.5
PEG (5Y)5.68
EPS Next 2Y8.3%
EPS Next 3Y8.22%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.61%, CNS has a reasonable but not impressive dividend return.
- CNS's Dividend Yield is comparable with the industry average which is at 5.87.
- CNS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.61% |
5.2 History
- The dividend of CNS decreases each year by -7.12%.
- CNS has paid a dividend for at least 10 years, which is a reliable track record.
- CNS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-7.12%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 76.25% of the earnings are spent on dividend by CNS. This is not a sustainable payout ratio.
DP76.25%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
COHEN & STEERS INC / CNS FAQ
What is the ChartMill fundamental rating of COHEN & STEERS INC (CNS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CNS.
What is the valuation status for CNS stock?
ChartMill assigns a valuation rating of 2 / 10 to COHEN & STEERS INC (CNS). This can be considered as Overvalued.
Can you provide the profitability details for COHEN & STEERS INC?
COHEN & STEERS INC (CNS) has a profitability rating of 7 / 10.
Can you provide the financial health for CNS stock?
The financial health rating of COHEN & STEERS INC (CNS) is 5 / 10.
What is the expected EPS growth for COHEN & STEERS INC (CNS) stock?
The Earnings per Share (EPS) of COHEN & STEERS INC (CNS) is expected to grow by 8.49% in the next year.